OKYO Pharma Correlations

OKYO Stock  USD 1.01  0.03  2.88%   
The current 90-days correlation between OKYO Pharma and Bionomics Limited is -0.18 (i.e., Good diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as OKYO Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if OKYO Pharma Ltd moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

OKYO Pharma Correlation With Market

Good diversification

The correlation between OKYO Pharma Ltd and DJI is -0.05 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding OKYO Pharma Ltd and DJI in the same portfolio, assuming nothing else is changed.
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in OKYO Pharma Ltd. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.

Moving against OKYO Stock

  0.38A Agilent TechnologiesPairCorr
  0.36DOMH Dominari HoldingsPairCorr
  0.4CDTTW Conduit PharmaceuticalsPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
PXMDCADL
ANEBCADL
PXMDCINGW
CINGWCADL
CINGWANEB
PXMDANEB
  
High negative correlations   
PXMDUNCY
UNCYCINGW
UNCYCADL
UNCYANEB
CDIOCINGW
QNRXCINGW

Risk-Adjusted Indicators

There is a big difference between OKYO Stock performing well and OKYO Pharma Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze OKYO Pharma's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

OKYO Pharma Corporate Management